David R. Bauer
Lawyers
Filters
Inventiva $100 million at-the-market offering
The American depository shares are listed on Nasdaq
Bloom Energy $2.5 billion convertible senior notes offering
The 0% convertible senior notes are due 2030
Cybin $175 million registered direct offering
The common shares are dual-listed on the NYSE American and Cboe Canada
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
GSK exclusive license agreement with Empirico
We advised GSK on the transaction
RAPT Therapeutics $250 million follow-on offering
The shares are listed on the Nasdaq Global Market
Nurix Therapeutics $250 million stock offering
The stock is listed on the Nasdaq Global Market
Esperion Therapeutics follow-on offering
The shares are listed on Nasdaq
Turn Therapeutics direct listing
We advised Turn Therapeutics on its Nasdaq listing
Neptune $368 million IPO
The shares are listed on the New York Stock Exchange